Cerus (CERS) Net Margin (QoQ) (2010 - 2026)
Cerus (CERS) Net Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn |
| 10 | Cerus | 602.81 Mn | 522.39 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -143.00 |
| Dec 31, 2025 | -138.00 |
| Sep 30, 2025 | 104,452.00 |
| Jun 30, 2025 | -102,694.00 |
| Mar 31, 2025 | -1,493.00 |
| Dec 31, 2024 | 41,863.00 |
| Sep 30, 2024 | -40,236.00 |
| Jun 30, 2024 | 607.00 |
| Mar 31, 2024 | -2,451.00 |
| Dec 31, 2023 | 416,268.00 |
| Sep 30, 2023 | -412,912.00 |
| Jun 30, 2023 | 7,719.00 |
| Mar 31, 2023 | -10,381.00 |
| Dec 31, 2022 | 11,813.00 |
| Sep 30, 2022 | -10,535.00 |
| Jun 30, 2022 | 6,251.00 |
| Mar 31, 2022 | -8,522.00 |
| Dec 31, 2021 | 21,056.00 |
| Sep 30, 2021 | -10,345.00 |
| Jun 30, 2021 | 7,576.00 |